These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. Saijo M, Yasuda Y, Yabe H, Kato S, Suzutani T, De Clercq E, Niikura M, Maeda A, Kurane I, Morikawa S. J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436 [Abstract] [Full Text] [Related]
3. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation. Iino T, Gondo H, Ohno Y, Minagawa H, Iwasaki H, Maruyama T, Nakashima H, Niho Y. Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394 [Abstract] [Full Text] [Related]
4. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient. Arnulf B, Chebbi F, Lefrere F, Ait Arkoub Z, Varet B, Fillet AM. Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635 [Abstract] [Full Text] [Related]
11. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant. Blot N, Schneider P, Young P, Janvresse C, Dehesdin D, Tron P, Vannier JP. Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393 [Abstract] [Full Text] [Related]
12. [Resistance of herpes simplex viruses to antiviral drugs]. Scieux C, Bianchi A. Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160 [Abstract] [Full Text] [Related]
13. Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population. Darville JM, Ley BE, Roome AP, Foot AB. Bone Marrow Transplant; 1998 Sep; 22(6):587-9. PubMed ID: 9758349 [Abstract] [Full Text] [Related]
16. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome. Ziyaeyan M, Alborzi A, Japoni A, Kadivar M, Davarpanah MA, Pourabbas B, Abassian A. Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520 [Abstract] [Full Text] [Related]
18. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Chen Y, Scieux C, Garrait V, Socié G, Rocha V, Molina JM, Thouvenot D, Morfin F, Hocqueloux L, Garderet L, Espérou H, Sélimi F, Devergie A, Leleu G, Aymard M, Morinet F, Gluckman E, Ribaud P. Clin Infect Dis; 2000 Oct; 31(4):927-35. PubMed ID: 11049772 [Abstract] [Full Text] [Related]
19. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Snoeck R, Andrei G, Gérard M, Silverman A, Hedderman A, Balzarini J, Sadzot-Delvaux C, Tricot G, Clumeck N, De Clercq E. Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312 [Abstract] [Full Text] [Related]